Gut check: fecal transplants aim to calm HIV inflammation
NCT ID NCT06022406
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tested whether taking fecal transplants (FMT) in capsules could reduce gut inflammation in people with HIV who are on antiretroviral therapy (ART) but have a low CD4/CD8 ratio. Twenty participants were split into two groups: one received FMT capsules and the other received placebo. The goal was to see if FMT could improve gut health and lower inflammation, which may help control the disease long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chronic Viral Illness Service
Montreal, Quebec, H4A 3J1, Canada
Conditions
Explore the condition pages connected to this study.